These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14165621)

  • 1. [THE INFLUENCE OF THE CONTENT OF PLASMA FIBRINOGEN, THROMBOPLASTIN OF THE TISSUES, THROMBIN AND HEPARIN ON THE THROMBOELASTOGRAM].
    PARREIRA F
    Gaz Med Port; 1964; 17():81-135. PubMed ID: 14165621
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON THE CONDITIONS FOR THE FORMATION OF URINARY CYLINDERS].
    FREY J; JUERGENS J
    Med Klin; 1964 Apr; 59():560-7. PubMed ID: 14197215
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in fibrinogen level after infusion of thrombin and thromboplastin.
    MONKHOUSE FC; MILOJEVIC S
    Am J Physiol; 1960 Dec; 199():1165-8. PubMed ID: 13772038
    [No Abstract]   [Full Text] [Related]  

  • 4. AGGREGATION OF FIBRIN AND FIBRINOGEN BY TAME.
    ABILDGAARD U; GODAL HC
    Scand J Clin Lab Invest; 1964; 16():531-9. PubMed ID: 14209213
    [No Abstract]   [Full Text] [Related]  

  • 5. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of cobalt chloride on thrombocythemia, on prothrombin time and on the plasma thromboelastogram].
    FAENZI C; CECI A; DI GRANDI O
    Boll Soc Ital Biol Sper; 1962 Apr; 38():330-1. PubMed ID: 13891275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fluctuations in the level of prothrombin, thrombin, free heparin and the activity of thromboplastin in the blood of patients after surgery on the organs of the intestinal cavity].
    PANAKHIAN AG
    Khirurgiia (Mosk); 1960 May; 36():113-9. PubMed ID: 14430077
    [No Abstract]   [Full Text] [Related]  

  • 8. [The maximum width of the thromboelastogram studied as a function of the platelets and fibrinogen in leptospirosis].
    GRAZIOLI C; MONTEVERDE A; FUMAGALLI E
    Folia Med (Napoli); 1962 Oct; 45():886-96. PubMed ID: 13950019
    [No Abstract]   [Full Text] [Related]  

  • 9. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activated thromboplastin time, plasma heparin and plasma fibrinogen using the Fibrintimer 10].
    Khayat MC; Laforet F; Khayat A; Derlon A; Lequerrec A; Thomas M
    Ann Biol Clin (Paris); 1988; 46(8):696-700. PubMed ID: 3218791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ON QUANTITATIVE CHANGES IN FIBRINOGEN AND METHODS OF THEIR EXAMINATION].
    BALUDA VP; RUSAKOVA GP; TOKAREV OIu
    Lab Delo; 1964; 10():425-9. PubMed ID: 14258534
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect, in the presence and absence of ionized calcium, of certain antagonists of the thrombin conversion of fibrinogen].
    BURSTEIN M
    Arch Int Pharmacodyn Ther; 1951 Feb; 85(3-4):467-73. PubMed ID: 14830360
    [No Abstract]   [Full Text] [Related]  

  • 15. CIRCULATING FIBRINOGEN DEGRADATION PRODUCTS (FDP) IN DOG BLOOD AFTER INTRAVENOUS THROMBIN INFUSION.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1965 Mar; 13():12-24. PubMed ID: 14285962
    [No Abstract]   [Full Text] [Related]  

  • 16. STUDY OF THE ANTI-THROMBOTIC PROPERTIES OF DEXTRANS OF LARGE MOLECULAR WEIGHT.
    BRYANT MF; BLOOM WL; BREWER SS
    J Cardiovasc Surg (Torino); 1964; 5():48-52. PubMed ID: 14109832
    [No Abstract]   [Full Text] [Related]  

  • 17. Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII.
    Nielsen VG; Kirklin JK
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):793-800. PubMed ID: 19002046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE EFFECT OF HEPARIN, HEPARINOIDS, AND OTHER ELECTRONEGATIVE COMPOUNDS ON THE IN VITRO THROMBIN-FIBRINOGEN CONVERSION AND ON WHOLE BLOOD CLOTTING TIME.
    SALAFSKY B; LOOMIS TA
    Arch Int Pharmacodyn Ther; 1964 Jul; 150():107-17. PubMed ID: 14204484
    [No Abstract]   [Full Text] [Related]  

  • 19. CHYMORAL AND COAGULATION.
    PESSEREAU G; MONTEIL R
    Rev Int Serv Sante Armees; 1963 Dec; 36():745-57. PubMed ID: 14102522
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE PHYSIOPATHOLOGY OF FIBRINOLYSIS AND ITS CLINICAL AND THERAPEUTIC APPLICATIONS].
    SAMAMA M
    Transfusion (Paris); 1964; 7():99-125. PubMed ID: 14168287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.